Art Krieg

All UI faculty, staff, postdocs, and students are invited to the Hawkeye Innovation Summit on April 23, 5:00-6:30pm for a reception and talk by Arthur Krieg, MD, titled "Shifting from R to D: The ABCs of translating a great scientific idea into a great startup."

Dr. Krieg's talk will cover how to identify research ideas with commercial value, and how to pitch your ideas to industry representatives. The session will include time for Q&A and a light reception for attendees. 

About the Speaker

Dr. Krieg recently founded Checkmate Pharmaceuticals to develop novel oligonucleotides for cancer immunotherapy. Prior to that role, he co-founded RaNA Therapeutics and the Coley Pharmaceutical Group, which was acquired by Pfizer in 2008.

Dr. Krieg received his MD from Washington University and completed a residency in Internal Medicine at the University of Minnesota. He was a Staff Fellow at the NIH before becoming Professor of Internal Medicine in the Division of Rheumatology at the University of Iowa.

He has published more than 250 scientific papers and is an inventor on 48 issued patents covering oligonucleotide technologies.

Session Details

Title: Shifting from R to D: The ABCs of translating a great scientific idea into a great startup
When: April 23, 5:00-6:30pm
Where: Nebraska Room, 335 Iowa Memorial Union
Registration is encouraged.

Hawkeye Innovation Summit

The third annual Hawkeye Innovation Summit is designed to bring together the UI's most innovative faculty, staff and students together in one place to celebrate successes, inspire new creations, and encourage networking for future collaborations.  It is hosted in collaboration with the John Pappajohn Entrepreneurial Center, Office of the Vice President for Research and Economic Development, University of Iowa Research Foundation, University of Iowa Research Park, and University of Iowa Small Business Development Center.